Press Releases

All Releases
Mar 08, 2017
AngioDynamics to Present at the Barclays Global Healthcare Conference
ALBANY, N.Y. , March 08, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
Jan 06, 2017
AngioDynamics Reports Fiscal 2017 Second Quarter Results
Q2 net sales of $89.0 million , down 0.3% year-over-year Q2 GAAP earnings per share of $0.37 ; non-GAAP adjusted EPS up 36% from Q2 Fiscal 2016 Q2 operating cash generation of $14.9 million ; free cash flow generation of $13.6 million Reiterated FY2017 revenue guidance; increased adjusted EPS and
Dec 20, 2016
AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 20, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 second
Nov 28, 2016
AngioDynamics to Participate in Upcoming Investor Conferences
ALBANY, N.Y. , Nov. 28, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is
Nov 09, 2016
AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc.
ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Eileen Auen and Jan Stern Reed to the
Oct 05, 2016
AngioDynamics Reports Fiscal 2017 First Quarter Results
Q1 net sales of $88.1 million , up 5% year-over-year Q1 GAAP earnings per share of $0.04 ; non-GAAP adjusted EPS of $0.17 Q1 operating cash generation of $7.4 million FY2017 guidance remains unchanged ALBANY, N.Y. , Oct. 05, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider
Sep 21, 2016
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
ALBANY, N.Y. , Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first
Apr 07, 2016
AngioDynamics Reports Fiscal 2016 Third Quarter Results
Net sales of $87.4 million , up 1% year-over-year GAAP earnings per share of $0.02 ; Non-GAAP adjusted EPS of $0.15 , up 25% year-over-year Operating cash generation of $12.4 million FY2016 financial guidance updated   ALBANY, N.Y. , April 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a
Displaying 61 - 80 of 648